Delivery Order SPE2DR25D2205-SPE2DR26F2A93
Award Date 2/10/26
Potential Completion Date 2/11/26
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $3,059.88 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for XCOPRI 200 mg tablets (30-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 6, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $3,529.49 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Xcopri 50 mg tablets (30-count packaging).</p> <p>Place of performance is Conshohocken, PA. The order has a completion date of February 10, 2026, and carries firm fixed pricing with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Xcopri 200 mg tablets (30-count) with a ceiling value of $3,728.73.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 6, 2026. The order is priced on a firm fixed-price basis with no set-aside.</p>
- The Defense Logistics Agency awarded a delivery order valued at $2,199.33 to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small transaction within AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency issued a $3,937.39 delivery order to AmerisourceBergen Drug Corp on February 9, 2026, for Xcopri 200 mg tablets (30-count). The order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies globally to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $5,280.21 for the supply of Xcopri 100 mg tablets (30-count units). Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical and medical supply procurement for military healthcare programs worldwide....
- The Defense Logistics Agency awarded a delivery order valued at $3,536.88 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 30, 2025, with a completion date of July 31, 2025, and performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's established capability to meet federal...
- The Defense Logistics Agency awarded a $2,432.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count units) with a completion date of August 4, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical supply transaction executed on August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 200 MG tablets (30-count) on October 22, 2025, with completion targeted for October 23, 2025. This competitively awarded, firm fixed-price contract involves performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified pharmaceutical distributors to support federal medical...
- This delivery order, awarded on January 20, 2026, to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency, procures 30-count tablets of XCOPRI 25 MG at a ceiling value of $1,901.43. The order is structured as a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This procurement was awarded on a fully competitive, non-set-aside...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2A93Delivery Order
The Defense Logistics Agency issued a $2,847.35 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for XCOPRI 150 mg tablets (30-count). Place of performance is Conshohocken, PA. The ultimate completion date is February 11, 2026. The order carries firm fixed pricing and was awarded without set-aside.
Generated 5/11/26, 11:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/9/26 |